| Previous Close | 32.58 |
| Open | 32.65 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 32.54 - 32.75 |
| 52 Week Range | 25.25 - 36.82 |
| Volume | 578,877 |
| Avg. Volume | 1,477,057 |
| Market Cap | 214.55B |
| Beta | 0.51 |
| PE Ratio (TTM) | 22.86 |
| EPS (TTM) | 1.43 |
| Earnings Date | N/A |
| Dividend & Yield | 1.03 (3.16%) |
| Ex-Dividend Date | 2017-03-15 |
| 1y Target Est | 35.43 |
- GlobeNewswire•2 hours ago
The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Roche Holding AG Shareholders and a Lead Plaintiff Deadline of August 7, 2017 (RHHBY)
NEW YORK, June 28, 2017-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Roche Holding AG who purchased shares between March 2, 2017 and June 5, ...
- PR Newswire•3 hours ago
Roche expands Harmony® Prenatal Test to include 22q11.2 deletion testing
-- New test option will be available globally mid-2017 in the Harmony CE-IVD kit and through the test send-out service from Ariosa Diagnostics Inc. OTCQX: RHHBY) today announced that it has added 22q11.2 deletion testing to the menu of the Harmony® Prenatal Test, a non-invasive prenatal testing service used for assessing the probability of Down syndrome (trisomy 21) and other chromosomal conditions in the fetus.
- Morningstar•7 hours ago
Healthcare: ACA Repeal Efforts Unlikely to Yield Major Legislative Changes
While the Republican-led Congress continues the push to repeal the Affordable Care Act, we still see challenges in passing any new legislation.